No results for ‘’
Dr Reddys Laboratories Ltd
₹1165.50
(1.97%)
Sun, 13 Sept 2026, 06:24 am
Health Technology
Pharmaceuticals: Major
24.5KDr Reddys Laboratories Share Price Live Chart
1 Day
(1.97%)
No Result Found
Summary
Market Cap (in Cr)
108751.63
Net Profit (in Cr)
5725.2
P/B
2.84
Sector P/E
33.76
P/E
16.87
EV/EBITDA
10.10
Debt/Equity (Industry)
0.16
Interest Cover (Industry)
17.01
ROCE (Industry)
16.41
RONW (Industry)
14.52
ROE
18.53
ROCE
23.05
Debt/Equity
0.11
EPS (TTM)
50.27
Dividend Yield
0.61
Book Value
453.98
Interest Cover
28.15
Analysis
all
- Dividends per share have increased over the past 10 years.
- Dividends paid are well covered by earnings (4.7x coverage).
- Dividends after 3 years are expected to be thoroughly covered by earnings (7.2x coverage).
- Dividends per share have been stable in the past 10 years.
- Dr. Reddy's Laboratories's earnings growth is expected to exceed the low risk savings rate of 7.2%.
- Dr. Reddy's Laboratories's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
- Dr. Reddy's Laboratories's dividend is below the markets top 25% of dividend payers in India (3.08%).
- Cash flow for Dr. Reddy's Laboratories is expected to increase but not above the 50% threshold in 2 years time.
- Dr. Reddy's Laboratories's earnings are expected to grow by 18.3% yearly, however this is not considered high growth (20% yearly).
- Dr. Reddy's Laboratories's earnings growth is positive but not above the India market average.
Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 26.63 | 26.64 | 26.64 | 26.64 | 26.64 |
| FII | 21.14 | 22.34 | 24.69 | 25.32 | 25.75 |
| DII | 30.72 | 30.44 | 27.98 | 26.74 | 25.62 |
| Public | 21.50 | 20.59 | 20.69 | 21.30 | 21.99 |
| Government | 0 | 0 | 0 | 0 | 0 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 1279.70 | 1226.00 | 1190.20 | 1172.30 | 1136.50 | 1118.60 | 1064.90 |
| Fibonacci | 1226.00 | 1205.49 | 1192.81 | 1172.30 | 1151.79 | 1139.11 | 1118.60 |
| Camarilla | 1169.17 | 1164.25 | 1159.32 | 1172.30 | 1149.48 | 1144.56 | 1139.63 |
Pivots Level: Classic
R3
+107.40
1279.70
R2
+53.70
1226.00
R1
+17.90
1190.20
S1
-35.80
1136.50
S2
-53.70
1118.60
S3
-107.40
1064.90
Moving Average
Period
Value
10-EMA
1156.64
20-EMA
1165.06
30-EMA
1174.33
50-EMA
1192.73
100-EMA
1220.92
200-EMA
1239.22
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 12 May 2026 | board-meetings | Accounts, Quarterly Results | |
| 12 May 2026 | agm | ||
| 21 Jan 2026 | board-meetings | Quarterly Results | |
| 10 Jun 2025 | dividend | Final Dividend - Rs. - 8 | 10 Jul 2025 |
| 09 May 2025 | agm | ||
| 09 May 2025 | dividend | ₹8.00 Dividend /Share | 10 Jul 2025 |
| 28 Sept 2024 | dividend | Face Value Split (Sub-Division) - From Rs 5/- Per Share To Re 1/- Per Share | 28 Oct 2024 |
| 28 Sept 2024 | split | Stock Split From Rs.5 to Rs.1 | 28 Oct 2024 |
| 27 Jul 2024 | split | 1:5 Splits of Equity Shares | 28 Oct 2024 |
| 16 Jun 2024 | dividend | Annual General Meeting/Dividend - Rs 40 Per Share | 17 Jul 2024 |
Peer Comparison
Dr Reddys Laboratories Ltd
Zydus Lifesciences Ltd
Sun Pharmaceutical Industries Ltd
Torrent Pharmaceuticals Ltd
Divis Laboratories Ltd
Cipla Ltd
Dr Reddys Laboratories Ltd About
Dr Reddys Laboratories offers a portfolio of products and services including active pharmaceutical ingredients (“APIs”), generics, branded generics, biosimilars, over the counter (“OTC”) products and pharmaceutical services.
Industry
Pharmaceuticals - Indian - Bulk Drugs & Formln
Founded
1984
Headquarters
CEO
K Satish Reddy
Employees
Contact
Website
http://www.drreddys.com
shares@drreddys.com; mail@drreddys.com
Phone
91-40-49002900
Location
8-2-337 Road No 3, Banjara Hills, Hyderabad, Telangana, 500034
Deals
| Client Name | Deal Type | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|---|
| KAPITALFORENINGEN INVESTIN PRO | block | Buy | 581268 | 1250.6 | 09 Sept 2025 |
| KAPITALFORENINGEN PENSAM INVEST | block | Sell | 581268 | 1250.6 | 09 Sept 2025 |
| THE MTBJ LTD. AS TRST FOR GOVERNMENT PENSION INVESTMENT FUND MTBJ400045849 | block | Buy | 141606 | 1254 | 14 Jul 2025 |
| THE MTBJ LTD. AS TRST FOR GOVRNMNT PENSION INVSTMNT FUND MTBJ400045828 | block | Sell | 141606 | 1254 | 14 Jul 2025 |
| BOFA SECURITIES EUROPE SA | block | Buy | 260000 | 6184.85 | 26 Mar 2024 |
| BOFA SECURITIES EUROPE SA | block | Sell | 260000 | 6184.85 | 26 Mar 2024 |
| THE JUPITER GLOBAL FUND-JUPITER INDIA SELECT | block | Buy | 31907 | 5645.45 | 18 Jan 2024 |
| JUPITER SOUTH ASIA INVESTMENT COMPANY LIMITED | block | Sell | 31907 | 5645.45 | 18 Jan 2024 |
| AIA INVESTMENT TRUST AIA SINGAPORE PARTCIPATING FUND HERITAGE SGD | block | Sell | 428 | 5355.2 | 26 Oct 2023 |
| AIA INVESTMENT TRUST AIA SINGAPORE PARTICIPATING FUND USD | block | Sell | 1551 | 5355.2 | 26 Oct 2023 |
Frequently Asked Questions
1.What is the stock price of Dr Reddys Laboratories Ltd?
As of 13/09/2026 at 11:54 AM, Dr Reddys Laboratories Ltd shares are trading at ₹1165.50.
2.What is the market cap. of Dr Reddys Laboratories Ltd?
As of 13/09/2026, the market capitalization of Dr Reddys Laboratories Ltd is ₹95,173.50 crore.
3.When was Dr Reddys Laboratories Ltd founded?
Dr Reddys Laboratories Ltd was founded in 1984.
4.What are the P/E and P/B ratios of Dr Reddys Laboratories Ltd?
As of 13/09/2026, Dr Reddys Laboratories Ltd has a P/E ratio of 29.37 and a P/B ratio of 2.84.
5.How can I buy shares of Dr Reddys Laboratories Ltd?
You can buy shares of Dr Reddys Laboratories Ltd through Pocketful. Simply open a Demat account, complete your KYC, add funds, and place a buy order.
6.What is the shareholding pattern of Dr Reddys Laboratories Ltd?
As of March,2026, promoters hold 26.63% in Dr Reddys Laboratories Ltd, while FIIs, DIIs and public shareholders hold 21.14%, 30.72% and 21.50%, respectively.
7.Does Dr Reddys Laboratories Ltd pay dividends?
Yes, Dr Reddys Laboratories Ltd pays dividends to eligible shareholders. The latest dividend announced by the company was ₹Final Dividend - Rs. - 8 per share.
8.What is the dividend yield of Dr Reddys Laboratories Ltd?
As of 13 September, 2026, the dividend yield of Dr Reddys Laboratories Ltd stands at 0.70%.
9.What are the latest financial results of Dr Reddys Laboratories Ltd?
For January,2024, Dr Reddys Laboratories Ltd reported revenue of ₹32,554.00 crore and a net profit of ₹5,654.00 crore.
10.What is the Stock symbol of Dr Reddys Laboratories Ltd?
DRREDDY is the stock symbol of Dr Reddys Laboratories Ltd.
11.Who is the CEO of Dr Reddys Laboratories Ltd?
The CEO of Dr Reddys Laboratories Ltd is K Satish Reddy.